This inventor holds 4 USPTO granted patents. Top assignee: Delalande S.a.. Active years: 1984-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984-1990
Title: Margherita Strolin-Benedetti: Innovator in Therapeutics
Introduction
Margherita Strolin-Benedetti is a prominent inventor based in Paris, France. She has made significant contributions to the field of therapeutics, particularly in the development of innovative compounds. With a total of four patents to her name, her work has garnered attention in the scientific community.
Latest Patents
Her latest patents include the development of 5-aminoethyloxazolidin-2-one derivatives. This invention involves a mixture of the four stereoisomers of a specific formula, which has applications as monoamine oxidase inhibitors. These compounds are designed to enhance therapeutic efficacy and provide new avenues for treatment.
Career Highlights
Margherita works at Delalande S.A., where she continues to push the boundaries of pharmaceutical innovation. Her research focuses on optically active derivatives of N-arylated oxazolidine-2-one, showcasing her expertise in medicinal chemistry.
Collaborations
She collaborates with esteemed colleagues such as Philippe L. Dostert and Michel Langlois, contributing to a dynamic research environment that fosters innovation.
Conclusion
Margherita Strolin-Benedetti's work exemplifies the spirit of innovation in the field of therapeutics. Her contributions are paving the way for new treatments and enhancing our understanding of medicinal compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile